Swedbank Strategists See No Reason to Change Equity Allocation
Swedbank strategists Mattias Isakson and Daniel Grythberg said the bank sees no reason to adjust its equity weighting amid market turbulence linked to fears about AI expansion.
Related stories
CG Oncology Reports Third-Quarter 2026 Financial Results and Business Updates
CG Oncology reported results for the quarter ended September 30, 2026. The company said it expects to share PIVOT-006 topline data this month.
M impact | EQUITY | Nov 06, 2026, 01:33 PM UTC
CG Oncology Q3 Net Loss Widens on Higher R&D Costs
M impact | EQUITY | Nov 06, 2026, 01:25 PM UTC
Tredegar Reports Third-Quarter 2026 Results
Tredegar reported financial results for the period ended September 30, 2026.
M impact | EQUITY | Nov 06, 2026, 01:23 PM UTC
Aura Minerals Q3 Revenue Beats Estimates on Record Production
M impact | EQUITY | Nov 06, 2026, 01:21 PM UTC
Aura Minerals Q3 Revenue Rose 56% to $386.0 Million
Q3 2026 revenue rose 56% year over year to $386.0 million. Adjusted EBITDA also rose 56% to $236.9 million; nine-month revenue was $1,104.6 million, up 84%, and net income was $447
M impact | EQUITY | Nov 06, 2026, 01:16 PM UTC
Aura Minerals Announces Q3 and Nine-Month 2026 Results
Aura Minerals says it filed its audited consolidated financial statements and earnings release for the periods ended in Q3 and the first nine months of 2026.
M impact | EQUITY | Nov 06, 2026, 01:16 PM UTC